Lisata Therapeutics Inc. Common Stock LSTA · Stock Open Lisata Therapeutics Inc. Common Stock in new tab
Lisata Therapeutics Inc. Common Stock Analysis (LSTA)
Is Lisata Therapeutics Inc. Common Stock a good investment? Lisata Therapeutics Inc. Common Stock (LSTA) is currently trading at 1.06 USD.
Earnings Schedule: Lisata Therapeutics Inc. Common Stock is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is -1.16.
Investor FAQ
Does Lisata Therapeutics Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Lisata Therapeutics Inc. Common Stock?
Lisata Therapeutics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of -1.64.
Company Profile
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
| Year | Total Dividends |
|---|---|
| ▸2013 |
0.00 USD
|
| Oct. 28, 2013 | 0.0021 |
| ▸2011 |
0.00 USD
|
| April 4, 2011 | 0.0002 |
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 31, 2006 | 1:10 |
| Aug. 9, 2007 | 1:10 |
| July 16, 2013 | 1:10 |
| July 28, 2016 | 1:10 |
| Sept. 15, 2022 | 1:15 |
Community Discussion